Report Detail
Global Argatroban Market Growth 2019-2024
- RnM2938470 |
- 13 February, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.
Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.
The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.
China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.
Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.
According to this study, over the next five years the Argatroban market will register a -14.9% CAGR in terms of revenue, the global market size will reach US$ 32 million by 2024, from US$ 84 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Argatroban business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Argatroban market by product type, application, key manufacturers and key regions and countries.
This study considers the Argatroban value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Argatroban Powder
Argatroban Injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Argatroban consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Argatroban market by identifying its various subsegments.
Focuses on the key global Argatroban manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Argatroban with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Argatroban submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Argatroban Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Argatroban Consumption 2014-2024
- 2.1.2 Argatroban Consumption CAGR by Region
- 2.2 Argatroban Segment by Type
- 2.2.1 Argatroban Powder
- 2.2.2 Argatroban Injection
- 2.3 Argatroban Consumption by Type
- 2.3.1 Global Argatroban Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Argatroban Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Argatroban Sale Price by Type (2014-2019)
- 2.4 Argatroban Segment by Application
- 2.4.1 Heparin-induced thrombocytopenia (HIT)
- 2.4.2 Percutaneous Coronary Intervention
- 2.4.3 Cerebral arterial thrombosis
- 2.5 Argatroban Consumption by Application
- 2.5.1 Global Argatroban Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Argatroban Value and Market Share by Application (2014-2019)
- 2.5.3 Global Argatroban Sale Price by Application (2014-2019)
3 Global Argatroban by Players
- 3.1 Global Argatroban Sales Market Share by Players
- 3.1.1 Global Argatroban Sales by Players (2017-2019)
- 3.1.2 Global Argatroban Sales Market Share by Players (2017-2019)
- 3.2 Global Argatroban Revenue Market Share by Players
- 3.2.1 Global Argatroban Revenue by Players (2017-2019)
- 3.2.2 Global Argatroban Revenue Market Share by Players (2017-2019)
- 3.3 Global Argatroban Sale Price by Players
- 3.4 Global Argatroban Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Argatroban Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Argatroban Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Argatroban by Regions
- 4.1 Argatroban by Regions
- 4.1.1 Global Argatroban Consumption by Regions
- 4.1.2 Global Argatroban Value by Regions
- 4.2 Americas Argatroban Consumption Growth
- 4.3 APAC Argatroban Consumption Growth
- 4.4 Europe Argatroban Consumption Growth
- 4.5 Middle East & Africa Argatroban Consumption Growth
5 Americas
- 5.1 Americas Argatroban Consumption by Countries
- 5.1.1 Americas Argatroban Consumption by Countries (2014-2019)
- 5.1.2 Americas Argatroban Value by Countries (2014-2019)
- 5.2 Americas Argatroban Consumption by Type
- 5.3 Americas Argatroban Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Argatroban Consumption by Countries
- 6.1.1 APAC Argatroban Consumption by Countries (2014-2019)
- 6.1.2 APAC Argatroban Value by Countries (2014-2019)
- 6.2 APAC Argatroban Consumption by Type
- 6.3 APAC Argatroban Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Argatroban by Countries
- 7.1.1 Europe Argatroban Consumption by Countries (2014-2019)
- 7.1.2 Europe Argatroban Value by Countries (2014-2019)
- 7.2 Europe Argatroban Consumption by Type
- 7.3 Europe Argatroban Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Argatroban by Countries
- 8.1.1 Middle East & Africa Argatroban Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Argatroban Value by Countries (2014-2019)
- 8.2 Middle East & Africa Argatroban Consumption by Type
- 8.3 Middle East & Africa Argatroban Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Argatroban Distributors
- 10.3 Argatroban Customer
11 Global Argatroban Market Forecast
- 11.1 Global Argatroban Consumption Forecast (2019-2024)
- 11.2 Global Argatroban Forecast by Regions
- 11.2.1 Global Argatroban Forecast by Regions (2019-2024)
- 11.2.2 Global Argatroban Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Argatroban Forecast by Type
- 11.8 Global Argatroban Forecast by Application
12 Key Players Analysis
- 12.1 Pfizer, Inc
- 12.1.1 Company Details
- 12.1.2 Argatroban Product Offered
- 12.1.3 Pfizer, Inc Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Pfizer, Inc News
- 12.2 SANDOZ
- 12.2.1 Company Details
- 12.2.2 Argatroban Product Offered
- 12.2.3 SANDOZ Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 SANDOZ News
- 12.3 GlaxoSmithKline Plc
- 12.3.1 Company Details
- 12.3.2 Argatroban Product Offered
- 12.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 GlaxoSmithKline Plc News
- 12.4 fresenius-kabi
- 12.4.1 Company Details
- 12.4.2 Argatroban Product Offered
- 12.4.3 fresenius-kabi Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 fresenius-kabi News
- 12.5 Eagle Pharmaceuticals, Inc
- 12.5.1 Company Details
- 12.5.2 Argatroban Product Offered
- 12.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Eagle Pharmaceuticals, Inc News
- 12.6 Mitsubishi Tanabe Pharma
- 12.6.1 Company Details
- 12.6.2 Argatroban Product Offered
- 12.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Mitsubishi Tanabe Pharma News
- 12.7 Teva Pharmaceutical Industries Ltd
- 12.7.1 Company Details
- 12.7.2 Argatroban Product Offered
- 12.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Teva Pharmaceutical Industries Ltd News
- 12.8 WEST-WARD,INC
- 12.8.1 Company Details
- 12.8.2 Argatroban Product Offered
- 12.8.3 WEST-WARD,INC Argatroban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 WEST-WARD,INC News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Argatroban . Industry analysis & Market Report on Argatroban is a syndicated market report, published as Global Argatroban Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Argatroban market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
